All
Results: 5017-5028 of 75893

Beyond Mobile Phones: Keypasco Digital helps Australian schools build banking‑grade campus cybersecurity protection

Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet

ESGE Days 2026: Endoscopic procedure associated with greater short-term weight loss than oral semaglutide, study finds






